Colmar, France

Nicolas Madit



Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Mulhouse, FR (1997)
  • Colmar Cedex, FR (2007)
  • Brunstatt, FR (2014)

Company Filing History:


Years Active: 1997-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Nicolas Madit: Innovator in Pharmaceutical Delivery Systems

Introduction

Nicolas Madit is a notable inventor based in Colmar, France. He has made significant contributions to the field of pharmaceutical delivery systems, holding a total of 3 patents. His work focuses on innovative solutions that enhance the efficacy and stability of drug formulations.

Latest Patents

One of his latest patents is the "Liquid Filled Delivery System." This invention provides a delivery system that includes a container made from a film-forming composition containing at least one polysaccharide or polysaccharide derivative. The system also features a liquid fill comprising a matrix composition of at least one solvent that is both polar and hygroscopic, along with an active agent that is soluble in the solvent. Another significant patent is for "Ibuprofen Containing Hard Shell Capsules." This invention relates to stable and pharmaceutically acceptable compositions for liquid filling hard shell capsules, which are preferably clear and transparent.

Career Highlights

Throughout his career, Nicolas Madit has worked with prominent companies such as Warner-Lambert Company and Capsugel Belgium NV. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Nicolas has collaborated with notable individuals in the field, including Dominique Nicolas Cade and Emmanuelle Mireille Guillard. These partnerships have further enriched his work and contributions to pharmaceutical technology.

Conclusion

Nicolas Madit stands out as an innovative inventor in the pharmaceutical industry, with a focus on enhancing drug delivery systems. His patents reflect a commitment to improving the stability and effectiveness of pharmaceutical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…